The changes in circulating miRNA levels relate to the pathophysiological background of dyslipidaemia and/or the specific type of LDL receptor mutation (homozygote or heterozygote patients) in familial hypercholesterolemia. Here, LDLR is linked to familial hypercholesterolemia.